Xencor, Inc Income Taxes Paid
Xencor, Inc (XNCR) reported Income Taxes Paid of $4.13 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-05
- Xencor, Inc income taxes paid, net for the quarter ending 2026-06-30 was $1.12M, a 84.00% decline year-over-year.
- Xencor, Inc income taxes paid, net for the quarter ending 2026-03-31 was $3.01M.
- Xencor, Inc income taxes paid, net for the quarter ending 2025-12-31 was -$47.00K.
- Xencor, Inc income taxes paid, net for the quarter ending 2025-09-30 was $359.00K.
- Xencor, Inc income taxes paid, net for fiscal 2025 was $7.31M, a 19.87% increase from fiscal 2024.
- Xencor, Inc income taxes paid, net for fiscal 2024 was $6.10M.
- Xencor, Inc income taxes paid, net for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Xencor, Inc income taxes paid, net for fiscal 2022 was $700.00K.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $4.13M 10-Q · filed 2026-08-05 | $4.09M derived: sum of 3 quarters · filed 2026-08-05 | $4.45M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $3.01M 10-Q · filed 2026-05-06 | $2.97M derived: sum of 2 quarters · filed 2026-05-06 | $3.33M derived: sum of 3 quarters · filed 2026-05-06 | $10.33M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $312.00K derived: sum of 2 quarters · filed 2026-02-25 | $7.31M derived: sum of 3 quarters · filed 2026-08-05 | $7.31M 10-K · filed 2026-02-25 |
| 2025-09-30 | $359.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $7.36M derived: sum of 2 quarters · filed 2026-08-05 | $7.36M 10-Q · filed 2025-11-05 | $7.36M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $7.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $7.00M 10-Q · filed 2026-08-05 | $7.00M derived: sum of 3 quarters · filed 2026-08-05 | $7.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-05-06 | $0.00 derived: sum of 3 quarters · filed 2026-05-06 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $6.10M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $6.10M 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | $6.10M 10-Q · filed 2025-08-06 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 10-K · filed 2026-02-25 | |
| 2023-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2025-02-24 | $0.00 10-Q/A · filed 2025-02-24 | ||
| 2023-06-30 | $0.00 10-Q/A · filed 2025-02-24 | |||
| 2022-12-31 | $628.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $700.00K 10-K · filed 2025-02-27 | ||
| 2022-09-30 | $72.00K 10-Q · filed 2023-11-08 | |||
| 2021-12-31 | $0.00 10-K/A · filed 2025-02-24 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-27 | |||
| 2019-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $250.00K derived: sum of 2 quarters · filed 2022-02-24 | $400.00K 10-K · filed 2022-02-24 | |
| 2019-09-30 | $50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $200.00K 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | $150.00K 10-Q · filed 2020-08-05 | |||
| 2018-12-31 | $63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $63.00K derived: sum of 2 quarters · filed 2021-02-24 | $63.00K derived: sum of 3 quarters · filed 2021-02-24 | $233.00K 10-K · filed 2021-02-24 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $0.00 derived: sum of 2 quarters · filed 2019-11-05 | $170.00K 10-Q · filed 2019-11-05 | $349.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $170.00K 10-Q · filed 2019-08-07 | $349.00K derived: sum of 3 quarters · filed 2020-02-25 | $1.08M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $170.00K 10-Q · filed 2019-05-09 | $349.00K derived: sum of 2 quarters · filed 2020-02-25 | $1.08M derived: sum of 3 quarters · filed 2020-02-25 | $1.08M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $909.00K derived: sum of 2 quarters · filed 2020-02-25 | $909.00K derived: sum of 3 quarters · filed 2020-02-25 | $969.00K 10-K · filed 2020-02-25 |
| 2017-09-30 | $730.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $730.00K derived: sum of 2 quarters · filed 2018-11-05 | $790.00K 10-Q · filed 2018-11-05 | $966.00K derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $60.00K 10-Q · filed 2018-08-07 | $236.00K derived: sum of 3 quarters · filed 2019-02-26 | |
| 2017-03-31 | $60.00K 10-Q · filed 2018-05-07 | $236.00K derived: sum of 2 quarters · filed 2019-02-26 | ||
| 2016-12-31 | $176.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $936.00K 10-K · filed 2019-02-26 | ||
| 2016-09-30 | $760.00K 10-Q · filed 2017-11-08 | |||
| 2015-12-31 | $1.00K 10-K · filed 2018-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |